Dr. Jack Kavanaugh
​
Ophthalmologist, Dentist and Entrepreneur
ABOUT
Dr. Jack Kavanaugh DDS, MD, MBA, founder and former Chairman/CEO of ZetaRx and a physician who has dedicated his career to accelerating disruptive medical technology development, is launching a cancer therapeutic company, Novonco Therapeutics, Inc., in partnership with Dr. David Horne from The City of Hope, Dr. Larry Overman from The University of California, Irvine, and The City of Hope.
​
Zeta RX was acquired in October 2013 by Juno Therapeutics, which was formed and launched on Zeta RX's technology as its core. Juno is continuing the work that Dr. Kavanaugh started and recently secured the largest series A raise in biotech history ($145 million) and has raised approximately $300 million in total.
​
​
Professional
Dr. Jack Kavanaugh has acquired considerable experience as both a dentist and an ophthalmologist treating pediatric and adult patients in California. Dr. Jack Kavanaugh plays a key role in the continued growth of a biotechnology company creating new methods to simplify the removal of ocular cataracts. His background as a physician and business executive has led to the development Kavanaugh has also helped in the commercialization of Calhoun Vision to create next-generation medical treatment equipment. Dr. Jack Kavanaugh is also a successful businessman who has been the driving force behind the commercialization of the cellular therapies and biotechnology companies.
Among Dr. Kavanaugh’s business accomplishments: As CEO and Chairman of ZetaRx Biosciences, Inc, he successfully combined the intellectual property from three globally-recognized health care and research institutions, assembled a highly respected management team, and lead the development of the FDA clinical trial strategy.
Jack Kavanaugh developed his amazing skills as an entrepreneur and contributes to the growth of many companies. He guides numerous physical science and biotech companies towards success with his vast knowledge.
EXPERIENCE
Dr. Jack Kavanaugh, M.D., DDS, MBA serves as Managing Member of General Partner, Multiverse Investment Fund I, LP at Multiverse Investment Fund. He also serves as Chairman and Chief Executive Officer of Nanotech Energy Inc. Dr. Kavanaugh is a Co-founder of Black Light Surgical, Inc., Fortem Neuroscience Inc., Hydrophilix, Inc., Nanotech Energy, Inc, LonglifeRx, Inc, SuperMetalix, Inc and Novonco Theraputics, Inc.